Danaher Corp (DHR): Debts to Book Capitalization

Graphic logo of Danaher Corporation (DHR)

Danaher Corp. is developing strategic alliances with pharmaceutical giants and research centers to create advanced diagnostics. The business relies on strong pricing power and acquisition synergies to ensure stable demand. The implementation of robotic systems is automating biopharmaceuticals. Regarding the financial stability indicator, the debt-to-capitalization ratio reflects asset dynamics, where 0.52 represents the latest metric reading.

Danaher Corp. - DHR Debts to Book Capitalization (period 07/04/2022 - 10/28/2026)

Metric breakdowns and analytics for Danaher Corporation (DHR)

- price and consensus price forecast:
Stock Price Danaher Corp.|DHR - Analyst Median Target
- market capitalization data:
Market Capitalization Danaher Corporation Inc.|DHR - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Danaher|DHR - Book Capitalization|Market Value to Book Value Ratio danaher.com|DHR - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Danaher Corp.|DHR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Danaher Corp|DHR - Company Total Debt Obligations|Debt to Book Capitalization Ratio Danaher Corporation Inc.|DHR - Company Long-Term Indebtedness|Company Short-Term Debt Danaher
Summary company analytics:DHR - Danaher Corp.
Core merchandise of Danaher Corporation

Danaher Corp. (DHR) dominance in the diagnostics segment and efficient management ensure high margins, allowing the company to optimize its debt load. An analysis of the total debt-to-capital ratio demonstrates the extent of asset dependence on borrowed funds, where reduced leverage confirms the issuer's financial stability and minimizes bankruptcy risks amid the Fed's tight monetary policy.

Who Danaher Corp. competes with

Debts to Book Capitalization ISRG|Debts to Net Assets bd.com BDX|STE: Debts to Book Capitalization|WST - Debt to Book Value|BAX: Debts to Book Capitalization|MASI (Masimo Inc.) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Stevanato Group S.p.A.|Debt to Book Capitalization Ratio teleflex.com (TFX)|Merit Medical (MMSI) - Debt to Book Value|Debt to Net Assets Ratio Envista Holdings Corporation (NVST)|Debts to Book Capitalization ICUI|Sirona Dental Systems - Debts to Net Assets|LeMaitre Vascular, Inc. (LMAT) - Debt to Book Capitalization Ratio|ATRC: Debt to Book Value Ratio|STAAR Surgical - Debt to Book Capitalization Ratio|Debts to Net Assets ChromaDex Corporation|ZimVie Dental (ZIMV) - Debt to Book Value|Debt to Book Capital ANGO|Cerus Corporation (CERS) - Debt to Book Capitalization Ratio|Debt to Net Assets Ratio teknova.com TKNO|Debt to Book Value MGRM (Monogram Orthopedics)|Sharps Technology Inc - Debts to Book Capitalization|INFU: Debt to Book Capitalization Ratio|UTMD - Debt to Book Value|Debts to Book Capitalization KRMD|NYXH (nyxoah.com) - Debts to Book Value|Debt to Book Capitalization Ratio Microbot Medical (MBOT)|Debt to Book Value Ratio Pro-Dex Inc (PDEX)|Debt to Book Value Zentek Limited|Debt to Book Capital ELUT (Elutia Corporation)|Debt to Book Capitalization Ratio MLSS|Debts to Net Assets nexgel.com NXGL|Retractable Tech (RVP) - Debts to Book Capitalization|HBIO - Debt to Book Value Ratio|FEMY: Debts to Book Capitalization|MHUA (Meihua Medical Technologies Co., Ltd.) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Predictive Oncology Inc (POAI)|Debt to Book Value Ratio Callan JMB Corp|Debts to Book Capitalization ATRI|Debts to Book Capitalization NeuroMetrix Inc (NURO)